Jenny Gunnarsson

机构：AstraZeneca (Singapore), AstraZeneca (Switzerland), AstraZeneca (Sweden), AstraZeneca (Germany)

发表论文 12 篇 · 总被引 232 次 · h-index 6

代表论文

• MALT1 Auto-Proteolysis Is Essential for NF-κB-Dependent Gene Transcription in Activated Lymphocytes (2014 · PLoS ONE · 被引 75)
• A class of highly selective inhibitors bind to an active state of PI3Kγ (2019 · Nature Chemical Biology · 被引 68)
• Drug Discovery at the Single Molecule Level: Inhibition-in-Solution Assay of Membrane-Reconstituted β-Secretase Using Single-Molecule Imaging (2015 · Analytical Chemistry · 被引 27)
• Design of recombinant antibody microarrays for membrane protein profiling of cell lysates and tissue extracts (2011 · PROTEOMICS · 被引 21)
• Exploring serial crystallography for drug discovery (2024 · IUCrJ · 被引 17)
• Structural analysis of the LDL receptor–interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding site (2020 · Journal of Biological Chemistry · 被引 12)